JPMorgan Chase & Co’s Kindred Biosciences, Inc. KIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-498,252
Closed -$4.57M 5963
2021
Q2
$4.57M Buy
498,252
+378,863
+317% +$3.47M ﹤0.01% 2706
2021
Q1
$593K Buy
119,389
+8,502
+8% +$42.2K ﹤0.01% 3952
2020
Q4
$478K Buy
110,887
+75,666
+215% +$326K ﹤0.01% 3772
2020
Q3
$155K Sell
35,221
-10,056
-22% -$44.3K ﹤0.01% 3853
2020
Q2
$203K Buy
45,277
+33,097
+272% +$148K ﹤0.01% 3658
2020
Q1
$49K Buy
12,180
+36
+0.3% +$145 ﹤0.01% 4146
2019
Q4
$103K Hold
12,144
﹤0.01% 4012
2019
Q3
$83K Buy
12,144
+1,970
+19% +$13.5K ﹤0.01% 4059
2019
Q2
$85K Sell
10,174
-35,222
-78% -$294K ﹤0.01% 4077
2019
Q1
$416K Buy
45,396
+30,966
+215% +$284K ﹤0.01% 3450
2018
Q4
$158K Sell
14,430
-9
-0.1% -$99 ﹤0.01% 3889
2018
Q3
$201K Sell
14,439
-7,088
-33% -$98.7K ﹤0.01% 3867
2018
Q2
$229K Buy
21,527
+16,406
+320% +$175K ﹤0.01% 3772
2018
Q1
$44K Sell
5,121
-3,683
-42% -$31.6K ﹤0.01% 4199
2017
Q4
$83K Buy
8,804
+3,900
+80% +$36.8K ﹤0.01% 3968
2017
Q3
$39K Sell
4,904
-8,912
-65% -$70.9K ﹤0.01% 3848
2017
Q2
$119K Buy
+13,816
New +$119K ﹤0.01% 3524
2016
Q3
Sell
-235,408
Closed -$833K 4347
2016
Q2
$833K Buy
235,408
+27,259
+13% +$96.5K ﹤0.01% 2818
2016
Q1
$718K Buy
+208,149
New +$718K ﹤0.01% 2800
2015
Q2
Sell
-156,500
Closed -$1.12M 3565
2015
Q1
$1.12M Sell
156,500
-19,500
-11% -$139K ﹤0.01% 2788
2014
Q4
$1.31M Sell
176,000
-45,800
-21% -$341K ﹤0.01% 2675
2014
Q3
$2.05M Buy
221,800
+79,500
+56% +$736K ﹤0.01% 2425
2014
Q2
$2.65M Buy
+142,300
New +$2.65M ﹤0.01% 2326